Phagelux (canada) Inc.

Precisionbiotix Technologies Inc.

Precisio Biotix Therapeutics, Inc.

Phagelux, Inc.

Precisiobiotix Technologies Inc.

Nancy Tawil

Ramaz Katsarava

David Tugushi

Vakhtang Beridze

Edwige Caroline Rebecca Arnold

Edwige Caroline Arnold

A method of eliminating, reducing or preventing bacterial contamination of a surface, the method comprising dispersing a bacteriophage containing composition in air in proximity to the surface. In some embodiments, the bacteriophage containing composition is a powder dispersed by pressurizing a load chamber containing the powder so that the powder is expelled through an outlet. Also, devices for performing the method and a powder used in the method.

Bacterial control through dispersion of bacteriophage powders

There is proposed a method for the sterilization of products containing bacteriophages in a manner that will allow the bacteriophages to retain their activity and infectivity. Products containing bacteriophages are exposed to supercritical COunder conditions causing little or no damage to structural integrity of the bacteriophages or to the structural properties of biodegradable scaffolds containing the bacteriophages.

Disinfection of bacteriophages products using supercritical carbon dioxide

A method of treating, reducing or preventing bacterial infection in a wound, the method comprising: applying a film on the wound, the film including a biodegradable polymer with bacteriophages dispersed therein, wherein the polymer is a poly (ester amide urea).

Composition comprising amino acid polymers and a bioactive agent and method of preparing thereof

An encapsulated bacteriophage formulation and a method for encapsulating bacteriophages and bacteriophage-related products in polymeric microcapsules is provided. Some embodiments of the method of producing the encapsulated bacteriophages involves a water-in-oil-in-water double emulsion.

Microencapsulation of bacteriophages and related products

Amino acid based polymers and polymer blends. Compositions comprising at least one amino acid based polymer or polymer blend, at least one bioactive agent, and optionally at least one filler. Additionally, compositions comprising at least one bacteriophage and at least one salt or buffer, which, for example, are in the form of a dry powder, and methods of preparing thereof are disclosed.

Growing community of inventors

Cantley, Canada

Nancy Tawil